Analysts Set R1 RCM Inc. (NASDAQ:RCM) Target Price at $15.41

Shares of R1 RCM Inc. (NASDAQ:RCM) have earned an average recommendation of “Hold” from the eighteen analysts that are currently covering the company, MarketBeat.com reports. Thirteen research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $15.41.

Several research analysts have commented on the stock. Leerink Partners lowered shares of R1 RCM from an “outperform” rating to a “market perform” rating and dropped their price objective for the stock from $17.00 to $14.30 in a research note on Thursday, August 1st. Jefferies Financial Group lowered R1 RCM from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Stephens downgraded R1 RCM from an “overweight” rating to an “equal weight” rating in a report on Thursday, August 1st. TD Cowen reiterated a “hold” rating and set a $14.30 target price (down from $20.00) on shares of R1 RCM in a research report on Monday, August 5th. Finally, Truist Financial reduced their price target on shares of R1 RCM from $16.00 to $14.30 and set a “hold” rating on the stock in a research note on Thursday, August 8th.

R1 RCM Price Performance

Shares of RCM opened at $14.31 on Thursday. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 0.76. R1 RCM has a 12-month low of $8.87 and a 12-month high of $15.12. The business’s 50 day moving average is $14.23 and its 200 day moving average is $13.47. The company has a market capitalization of $6.04 billion, a PE ratio of -95.39 and a beta of 0.84.

R1 RCM (NASDAQ:RCM) last issued its quarterly earnings data on Tuesday, November 5th. The healthcare provider reported ($0.05) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.04). The firm had revenue of $656.80 million for the quarter, compared to analysts’ expectations of $640.93 million. R1 RCM had a negative net margin of 2.48% and a negative return on equity of 2.18%. The business’s revenue for the quarter was up 14.7% compared to the same quarter last year. Research analysts expect that R1 RCM will post -0.18 earnings per share for the current fiscal year.

Institutional Trading of R1 RCM

Institutional investors have recently bought and sold shares of the business. GAMMA Investing LLC boosted its holdings in R1 RCM by 41.3% in the 3rd quarter. GAMMA Investing LLC now owns 2,597 shares of the healthcare provider’s stock worth $37,000 after buying an additional 759 shares during the last quarter. Arizona State Retirement System raised its holdings in R1 RCM by 2.1% in the 2nd quarter. Arizona State Retirement System now owns 47,063 shares of the healthcare provider’s stock valued at $591,000 after acquiring an additional 969 shares during the last quarter. QRG Capital Management Inc. raised its holdings in R1 RCM by 10.6% in the 2nd quarter. QRG Capital Management Inc. now owns 11,307 shares of the healthcare provider’s stock valued at $142,000 after acquiring an additional 1,080 shares during the last quarter. Advisors Asset Management Inc. purchased a new position in R1 RCM in the 1st quarter worth approximately $27,000. Finally, Victory Capital Management Inc. boosted its holdings in shares of R1 RCM by 7.7% during the 2nd quarter. Victory Capital Management Inc. now owns 36,006 shares of the healthcare provider’s stock worth $452,000 after purchasing an additional 2,574 shares during the last quarter. 61.10% of the stock is owned by institutional investors and hedge funds.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.